RAND Corporation Sep 16 2025 Sales of the overdose reversal medication naloxone increased after it was made available to the public without a prescription but then dipped quickly in the period following debut of over-the-counter sales, according to a new RAND study. Over-the-counter sales of naloxone peaked during the first month of availability in September 2023, then declined rapidly before stabilizing until August 2024, when there was a small increase, according to the study published in the